Evoke Wealth, LLC Novartis Ag Transaction History

Evoke Wealth, LLC

$3.68 Trillion
Q3 2024

A detailed history of Evoke Wealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Evoke Wealth, LLC holds 1,802 shares of NVS stock, worth $187,912. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,802

Holding current value

$187,912

% of portfolio

0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $191,246 - $217,843	1,802 New	1,802 $207 Million
Q3 2022 Nov 07, 2022	BUY	$74.61 - $87.26 $66,402 - $77,661	890 Added 47.04%	2,782 $211,000
Q2 2022 Aug 04, 2022	BUY	$80.52 - $93.75 $35,911 - $41,812	446 Added 30.84%	1,892 $160,000
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $10,679 - $11,809	-134 Reduced 8.48%	1,446 $126,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $4,825 - $5,613	59 Added 3.88%	1,580 $129,000
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $93,186 - $109,892	1,116 Added 275.56%	1,521 $130,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $43,719 - $52,880	-560 Reduced 58.03%	405 $38,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $45,834 - $50,778	558 Added 137.1%	965 $84,000
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $11,492 - $12,936	-142 Reduced 25.87%	407 $36,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $122,965 - $172,277	-1,740 Reduced 76.02%	549 $45.3 Million
Q4 2019 Feb 07, 2020	BUY	$84.35 - $95.37 $18,810 - $21,267	223 Added 10.79%	2,289 $217 Million
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $176,725 - $194,741	2,066 New	2,066 $180 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.

Account